Sunday - December 22, 2024

Determining Biological Properties of Atherosclerotic Plaque, Coronary Artery Disease, or Vasculopathy

2024-12-03

ALEXANDRIA, Virginia, Dec. 3 -- ELUCID BIOIMAGING INC., Boston, Massachusetts has been assigned a patent (No. US 12159406 B2, initially filed Dec. 19, 2023) developed by five inventors Andrew J. Buckler, Boston, Massachusetts; Kjell Johnson, Ann Arbor, Michigan; Xiaonan Ma, South Hamilton, Massachusetts; Keith A Moulton, Amesbury, Massachusetts; and David S. Paik, Boston, Massachusetts, for "Determining biological properties of atherosclerotic plaque, coronary artery disease, or vasculopathy." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Determining Biological Properties of Atherosclerotic Plaque, Coronary Artery Disease, or Vasculopathy

Information Request Form

Copyright Targeted News Service 2024